Literature DB >> 23386273

Dipeptidyl peptidase-4 inhibitors--emerging player for vascular protection.

Kimio Satoh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23386273     DOI： 10.1253/circj.cj-13-0064

Source DB:  PubMed          Journal:  Circ J        ISSN： 1346-9843            Impact factor:   2.993


× No keyword cloud information.
  3 in total

1.  Effects of linagliptin on renal endothelial function in patients with type 2 diabetes: a randomised clinical trial.

Authors:  Christian Ott; Iris Kistner; Mirjam Keller; Stefanie Friedrich; Carsten Willam; Peter Bramlage; Roland E Schmieder
Journal:  Diabetologia       Date:  2016-09-01       Impact factor: 10.122

Review 2.  Dipeptidyl peptidase-4(DPP-4) inhibitors: promising new agents for autoimmune diabetes.

Authors:  Xia Wang; Peilin Zheng; Gan Huang; Lin Yang; Zhiguang Zhou
Journal:  Clin Exp Med       Date:  2018-07-17       Impact factor: 3.984

3.  Hemorheologic Alterations in Patients with Type 2 Diabetes Mellitus Presented with an Acute Myocardial Infarction.

Authors:  Kyu Hwan Park; Ung Kim; Kang Un Choi; Jong Ho Nam; Jung Hee Lee; Chan Hee Lee; Jang Won Son; Jong Seon Park; Dong Gu Shin; Kyu Chang Won; Jun Sung Moon; Yu Kyung Kim; Jang Soo Suh
Journal:  Diabetes Metab J       Date:  2018-04       Impact factor: 5.376
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.